US OptionsDetailed Quotes
NOTV250117C5000
- 0.65
- +0.25+62.50%
15min DelayClose Dec 26 16:00 ET
0.70High0.40Low
0.55Open0.40Pre Close97 Volume345 Open Interest5.00Strike Price5.15KTurnover139.56%IV16.37%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier21DDays to Expiry0.65Extrinsic Value100Contract SizeAmericanOptions Type0.5362Delta0.2408Gamma8.09Leverage Ratio-0.0156Theta0.0012Rho4.34Eff Leverage0.0047Vega
Inotiv Stock Discussion
Sign in to post a comment
$Alpha Teknova (TKNO.US)$ $Inotiv (NOTV.US)$ $Dyadic (DYAI.US)$ $Safe Pro Group (SPAI.US)$ $Digital Ally (DGLY.US)$ $Williams-Sonoma (WSM.US)$ $Unusual Machines (UMAC.US)$ $Silexion Therapeutics (SLXN.US)$ $Kingsoft Cloud (KC.US)$ $Red Cat Holdings (RCAT.US)$ $Quantum Computing (QUBT.US)$ $Exicure (XCUR.US)$ $Forte Biosciences (FBRX.US)$ $Quantum-Si (QSI.US)$
📊⚡️📊
📊⚡️📊
2
1
$Inotiv (NOTV.US)$ what happend here
Inotiv's low P/S ratio may be due to investor worries about its future growth. The company's below-industry growth forecast could be causing shareholder unease, leading to a lower P/S ratio. A significant turnaround would be needed for the P/S ratio to increase.
Inotiv's P/S ratio lags behind peers despite upward share trends and high revenue growth, indicating potential lack of investor confidence in future growth. Unseen threats might be lowering the P/S ratio, risking near term underperformance.
Analysts are divided on Inotiv's future following varying price target predictions. Despite the expectation of increased losses next year, revenue estimates are steady. However, Inotiv's revenue growth is anticipated to decelerate, underperforming the broader industry.
$Abbott Laboratories (ABT.US)$ $Aptevo Therapeutics (APVO.US)$ $BioNexus Gene Lab (BGLC.US)$ $Codexis (CDXS.US)$ $Capital One Financial (COF.US)$ $CSX Corp (CSX.US)$ $Digital World Acquisition Corp (DWAC.US)$ $Evelo Biosciences (EVLO.US)$ $Guardforce AI (GFAI.US)$ $Intuitive Surgical (ISRG.US)$ $Joby Aviation (JOBY.US)$ $Inotiv (NOTV.US)$ $PainReform (PRFX.US)$ $Rambus (RMBS.US)$ $Sirius XM (SIRI.US)$ $22nd Century (XXII.US)$
3
2
QUICK SCALP 2 $NOTV - STOCK & OPTION PLAY
ALERT ON: $7.05
ON THE WATCH: $7.18
🥇 SIGNED OF MORE UPTREND: $7.33
NEED IT TO BREAK OVER: $7.44
key indicator for MORE uptrend $7.56
confirmation uptrend - $7.63
mini breakout - $7.74. $Inotiv (NOTV.US)$
ALERT ON: $7.05
ON THE WATCH: $7.18
🥇 SIGNED OF MORE UPTREND: $7.33
NEED IT TO BREAK OVER: $7.44
key indicator for MORE uptrend $7.56
confirmation uptrend - $7.63
mini breakout - $7.74. $Inotiv (NOTV.US)$
1
DAILY RECAP 12/12 👍🏼🔥
Stocks
APVO ⭐️⭐️⭐️ very good 5.49 to 7s 30%+
NOTV ⭐️⭐️ 4.21 ran to 4.70s 15%+
AMAM ⭐️⭐️ 2.79 ran to 3.40s 15%+
AFMD ⭐️⭐️⭐️1.22 zone ran to 1.40s 15%+
Options
CVX ⭐️⭐️ 2.64 to 2.90s 10%+ (potential hold)
TSLA ok to 1st-2nd target
Addition
COP to 112s am from Friday 20%
$Aptevo Therapeutics (APVO.US)$ $Inotiv (NOTV.US)$ $Ambrx Biopharma (AMAM.US)$ $Affimed NV (AFMD.US)$ $Chevron (CVX.US)$ $Tesla (TSLA.US)$ $ConocoPhillips (COP.US)$
Stocks
APVO ⭐️⭐️⭐️ very good 5.49 to 7s 30%+
NOTV ⭐️⭐️ 4.21 ran to 4.70s 15%+
AMAM ⭐️⭐️ 2.79 ran to 3.40s 15%+
AFMD ⭐️⭐️⭐️1.22 zone ran to 1.40s 15%+
Options
CVX ⭐️⭐️ 2.64 to 2.90s 10%+ (potential hold)
TSLA ok to 1st-2nd target
Addition
COP to 112s am from Friday 20%
$Aptevo Therapeutics (APVO.US)$ $Inotiv (NOTV.US)$ $Ambrx Biopharma (AMAM.US)$ $Affimed NV (AFMD.US)$ $Chevron (CVX.US)$ $Tesla (TSLA.US)$ $ConocoPhillips (COP.US)$
+3
1
2
No comment yet
ceoram : @Jaguar8 sleeper and upcoming earning report. Had a short run until it hit a sell off from what I’m seeing. Would like your perspective.